Leadership Overview
Baxter has 10 executives leading key functions including information technology, medical products, hospital operations, scientific research, surgical solutions, communications, integrated solutions, infusion therapies, bioscience, and regional management.
Driven by a commitment to patient care, Baxter is dedicated to advancing healthcare through innovative solutions that improve patient outcomes and enhance operational efficiency across the global healthcare landscape.
Driven by a commitment to patient care, Baxter is dedicated to advancing healthcare through innovative solutions that improve patient outcomes and enhance operational efficiency across the global healthcare landscape.
Leadership Roles at Baxter
Julie Foster - President, Front Line Care
Julie Foster, the President, Front Line Care at Baxter, leads the strategic direction and operational execution for a vital segment of the company's offerings. This leadership position involves overseeing the development, manufacturing, and distribution of products directly impacting patient care at the point of treatment, such as infusion pumps and critical care devices. Foster's responsibilities include driving innovation in technologies that support clinicians and patients in acute care settings, ensuring seamless integration into hospital workflows. By focusing on the needs of healthcare providers and patients, Julie Foster guides the Front Line Care division to deliver reliable and effective solutions that enhance patient outcomes and operational efficiency. The President's strategic oversight ensures this segment's continued growth and its contribution to Baxter's overall mission of advancing healthcare globally.
Stephen Wallace - President, Advanced Surgery
Stephen Wallace, the President, Advanced Surgery at Baxter, directs the strategic vision and operational performance of the company's advanced surgical solutions. This leadership role encompasses the development, marketing, and sales of innovative products designed to enhance surgical procedures and improve patient recovery. Wallace's focus is on driving growth within the surgical market by leveraging Baxter's expertise in biosurgery products and related technologies. By fostering collaboration between R&D, sales, and clinical teams, Stephen Wallace ensures that the Advanced Surgery division remains at the forefront of surgical innovation. The President's commitment to excellence supports the delivery of high-quality surgical tools and therapies that benefit both healthcare providers and patients, solidifying Baxter's position as a leader in surgical care.
Stacey Eisen - Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation
Stacey Eisen, the Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation at Baxter, leads the company's external and internal communications, corporate branding, and philanthropic initiatives. This multifaceted role involves shaping Baxter's public image, managing stakeholder relations, and driving marketing strategies that highlight the company's commitment to advancing healthcare. Eisen's leadership ensures consistent messaging across all platforms, reinforcing Baxter's mission and values. As President of the Baxter Foundation, Stacey Eisen oversees the strategic allocation of resources to support community health programs and global initiatives, further demonstrating the company's dedication to social responsibility. The Chief Communications Officer's efforts are crucial in building trust and enhancing Baxter's reputation among patients, healthcare professionals, and the broader community.
Donny Patel - President, Connected Care, Integrated Solutions
Donny Patel, the President, Connected Care, Integrated Solutions at Baxter, drives the strategy and execution for solutions that enhance patient monitoring and care delivery outside traditional hospital settings. This leadership position focuses on developing and deploying technologies that enable seamless communication between patients, caregivers, and healthcare providers, particularly in home-based and remote care environments. Patel's oversight includes the integration of digital health tools and connected devices that support Baxter's renal and hospital product lines, ensuring continuity of care. By championing innovative approaches to integrated solutions, Donny Patel supports Baxter's mission to improve patient outcomes and operational efficiency across the healthcare continuum. The President's focus on connected care is pivotal in expanding access to essential medical therapies and services.
Cecilia Soriano - Group President, Infusion Therapies Technologies & Pharmaceuticals
Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, leads a critical segment focused on delivering essential therapies and advanced technologies for infusion and pharmaceutical applications. This executive role involves overseeing the development, manufacturing, and commercialization of a broad range of products, including IV solutions, premixed drugs, and infusion pumps, which are vital in hospital and home settings. Soriano's strategic direction ensures that Baxter provides high-quality, reliable solutions that meet the complex needs of patients and healthcare providers worldwide. By driving innovation in infusion technologies and pharmaceutical delivery systems, Cecilia Soriano enhances patient safety and treatment efficacy. The Group President's leadership is instrumental in maintaining Baxter's strong market position and expanding access to life-sustaining therapies.
Joy Amundson - CVP and President Baxter BioScience
Joy Amundson, the CVP and President Baxter BioScience at Baxter, directs the strategic growth and operational excellence of the company's bioscience division. This leadership role is pivotal in advancing Baxter's capabilities in developing and manufacturing critical biological products and therapies. Amundson's responsibilities include overseeing research and development, ensuring product quality and compliance with global regulatory standards, and driving market expansion for Baxter's bioscience portfolio. By fostering scientific innovation and operational efficiency, Joy Amundson contributes significantly to Baxter's mission of saving and sustaining lives. The President's focus on the bioscience sector underscores Baxter's commitment to providing advanced medical solutions that address complex health challenges and improve patient outcomes globally.
Glen Argyle - General Manager, President & Representative Director
Glen Argyle, the General Manager, President & Representative Director at Baxter, holds a key leadership position overseeing significant regional operations and strategic initiatives. This role involves driving business performance, ensuring operational efficiency, and fostering market growth within the designated geographical area. Argyle's responsibilities include aligning local strategies with Baxter's global objectives, managing stakeholder relationships, and championing the company's commitment to delivering high-quality healthcare products and services. By providing strong leadership and strategic oversight, Glen Argyle ensures that Baxter's operations in the region effectively meet the needs of patients and healthcare providers. The President's dedication to excellence supports Baxter's overarching mission to advance healthcare and improve lives worldwide.
Rusty Patel - Senior Vice President & Chief Information Officer
Rusty Patel, the Senior Vice President & Chief Information Officer at Baxter, directs the company's global information technology strategy and operations. Overseeing all aspects of the IT infrastructure, Patel ensures the secure and efficient delivery of technology solutions that support Baxter's diverse product portfolio, including renal and hospital products. This leadership role involves driving digital transformation initiatives, enhancing cybersecurity measures, and optimizing data management systems to support business objectives. Patel's oversight extends to the development and implementation of enterprise-wide IT policies and procedures, ensuring compliance and operational excellence. By fostering innovation within the IT department, Rusty Patel enables the seamless integration of new technologies that advance Baxter's mission in providing critical healthcare solutions worldwide. The Chief Information Officer's strategic vision ensures technology underpins every facet of the company's operations, from product development to patient care delivery.
Olga Selina - Vice President, Information Technology Artificial Intelligence (Ai) & Data, Medical Products & Therapies Information (Segment Technology Leader & Chief Information Officer
Olga Selina, the Vice President, Information Technology Artificial Intelligence (Ai) & Data, Medical Products & Therapies Information (Segment Technology Leader & Chief Information Officer at Baxter, spearheads the integration of artificial intelligence and advanced data analytics within the Medical Products & Therapies segment. This critical role involves developing and executing AI strategies to enhance product development, improve manufacturing processes, and optimize patient treatment pathways. Selina's leadership ensures that data-driven insights are leveraged to drive innovation and efficiency across Baxter's hospital product offerings, including IV solutions, premixed drugs, and infusion pumps. By championing the use of AI and data science, Olga Selina supports the segment's ability to deliver cutting-edge medical technologies. The Chief Information Officer's focus on data governance and AI implementation directly contributes to the segment's technological advancement and market competitiveness, ensuring Baxter remains at the forefront of medical innovation.
Tobi Karchmer - Senior VP & Chief Medical & Scientific Officer
Tobi Karchmer, the Senior VP & Chief Medical & Scientific Officer at Baxter, provides critical medical and scientific leadership across the organization. This executive role involves guiding research and development initiatives, ensuring the clinical efficacy and safety of Baxter's product portfolio, which spans renal therapies and hospital products. Karchmer's expertise is essential in translating scientific discoveries into innovative healthcare solutions that address unmet medical needs. By overseeing clinical trials, regulatory affairs, and scientific communications, Tobi Karchmer ensures that Baxter's products meet the highest standards of medical and scientific integrity. The Chief Medical & Scientific Officer's strategic input is vital for shaping the company's long-term research agenda and fostering collaborations with the global scientific community, reinforcing Baxter's commitment to advancing patient care through evidence-based innovation.
Explore Leadership Teams in Manufacturing
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
TS
VN
Founded in 1989, Vertex Pharmaceuticals is a global biotechnology company focused on the discovery, development and commercialization of drugs for a range of serious diseases. Located in Boston, Massachusetts.
Company Leadership
SF
DD
USV Private Limited is an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India. USV Limited was established in 1961.
Company Leadership SY
AM
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan.
Company Leadership TM
CP
GP
Frequently Asked Questions Regarding Baxter Top Executives and Leadership Team
Unlock more people and company data
